Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
about
Potential role for metformin in urologic oncologyAndrogen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.The HIF/PHF8/AR axis promotes prostate cancer progression.Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression.Androgen receptor variation affects prostate cancer progression and drug resistance.The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer.
P2860
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dual targeting of the androgen ...... sistant prostate cancer cells.
@ast
Dual targeting of the androgen ...... sistant prostate cancer cells.
@en
type
label
Dual targeting of the androgen ...... sistant prostate cancer cells.
@ast
Dual targeting of the androgen ...... sistant prostate cancer cells.
@en
prefLabel
Dual targeting of the androgen ...... sistant prostate cancer cells.
@ast
Dual targeting of the androgen ...... sistant prostate cancer cells.
@en
P2093
P2860
P356
P1476
Dual targeting of the androgen ...... sistant prostate cancer cells.
@en
P2093
Ariel M Ley
Cindy H Chau
Douglas K Price
Elena V Fernandez
Kelie M Reece
Sarah M Troutman
Tristan M Sissung
William D Figg
P2860
P304
P356
10.1124/MOL.114.097477
P577
2015-03-31T00:00:00Z